サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1362973

ヘリコバクター・ピロリ感染診断の市場規模、シェア、動向分析レポート：タイプ別、技術別、最終用途別、地域別、セグメント予測、2023年～2030年

Helicobacter Pylori Diagnostics Market Size, Share & Trends Analysis Report By Type (Instruments, Reagents), By Technology (Immunoassays, POC), By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ヘリコバクター・ピロリ感染診断の市場規模、シェア、動向分析レポート：タイプ別、技術別、最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月12日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヘリコバクター・ピロリ感染診断市場の成長と動向：

Grand View Research社の最新レポートによると、世界のヘリコバクター・ピロリ感染診断市場規模は2030年までに7億5,784万米ドルに達すると予測されています。

予測期間のCAGRは4.5%で拡大する見込みです。ヘリコバクター・ピロリ（H. pylori）感染診断の費用対効果の向上と相まって、個別化された抗生物質療法に対する需要の増加が成長を促進すると予測されています。

抗生物質の入手のしやすさと手頃な価格、短い治療期間が、抗生物質の採用や前後のモニタリング検査の需要を押し上げると予想されます。さらに、ピロリ菌感染症の罹患率の上昇、早期診断の必要性、診断技術における急速な技術進歩などの要因が市場の成長を促進します。しかし、競争の激しい環境による経済的な価格維持のプレッシャーの高まりは、ヘリコバクター・ピロリ感染診断市場の成長を阻害する可能性があります。

ピロリ菌は好気性のグラム陰性菌で、一般に胃に存在します。胃の生態系のバランスを保つのに有利ではあるが、胃の内壁に感染を引き起こす可能性があります。この細菌は、胃がん、十二指腸潰瘍、胃炎や胃潰瘍、小腸への感染症などの原因菌の一つとして作用する可能性があります。そのため、ピロリ菌感染の早期発見を可能にするヘリコバクター・ピロリ感染診断の需要が高まっています。ピロリ菌による潰瘍が陽性と診断された場合、患者は10～14日間の抗生物質治療を受けることになります。ピロリ菌の治療には、メトロニダゾール、アモキシシリン、クラリスロマイシン、テトラサイクリンなどの抗生物質の併用や、プロトンポンプ阻害薬、クエン酸ラニチジンビスマス、サブサリチル酸ビスマスなどの併用が考えられます。

イムノアッセイ技術セグメントは2018年に最大の市場シェアを占め、予測期間中に最も速いCAGRを記録すると予測されています。エンドユーザーでは、病院セグメントが2018年に最大の市場シェアを占めましたが、診断研究所は今後数年間で最も速いCAGRで拡大すると予測されています。地域別では、北米がヘリコバクター・ピロリ感染診断の世界市場をリードしました。一方、アジア太平洋は2019年から2026年にかけて最も速いCAGRを記録すると予測されています。

ヘリコバクター・ピロリ感染診断市場レポートハイライト

  • イムノアッセイ技術が2022年に最大の市場シェアを占め、予測期間中に最速のCAGRが見込まれます。
  • エンドユーザーの中では、病院セグメントが2022年に最大の市場シェアを占め、診断ラボセグメントが2023年から2030年にかけて最も速いCAGRを示すと予測されます。
  • ラテンアメリカは、医療分野の重要性の高まり、感染症の流行、意識の高まりにより、予測期間中にCAGR 6.4％で急成長すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ヘリコバクター・ピロリ感染診断市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • ヘリコバクター・ピロリ感染診断市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 ヘリコバクター・ピロリ感染診断市場：タイプの推定・動向分析

  • ヘリコバクター・ピロリ感染診断市場：重要なポイント
  • ヘリコバクター・ピロリ感染診断市場：動向と市場シェア分析、2022年および2030年
  • 機器
  • 試薬
  • サービス

第5章 ヘリコバクター・ピロリ感染診断市場：技術の推定・動向分析

  • ヘリコバクター・ピロリ感染診断市場：重要なポイント
  • ヘリコバクター・ピロリ感染診断市場：動向と市場シェア分析、2022年および2030年
  • イムノアッセイ
  • POC
  • 分子診断

第6章 ヘリコバクター・ピロリ感染診断：エンドユーザーの推定・動向分析

  • ヘリコバクター・ピロリ感染診断市場：重要なポイント
  • ヘリコバクター・ピロリ感染診断市場：動向と市場シェア分析、2022年および2030年
  • 病院
  • 診断研究所
  • クリニック

第7章 ヘリコバクター・ピロリ感染診断市場：地域の推定・動向分析

  • 地域別の見通し
  • 地域別のヘリコバクター・ピロリ感染診断市場：重要なポイント
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Thermo Fisher Scientific
    • Biohit Oyj
    • Quest Diagnostics Incorporated
    • Meridian Bioscience
    • Bio-Rad Laboratories
    • Alpha Laboratories Ltd
    • F. Hoffmann-La Roche Ltd
    • Coris BioConcept
    • Certest Biotec
    • Epitope Diagnostics, Inc.
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America helicobacter pylori diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 13 Europe helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Europe helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe helicobacter pylori diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 23 France helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 24 France helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Italy helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 29 Spain helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Spain helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Sweden helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 32 Sweden helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Sweden helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Norway helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 35 Norway helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Norway helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Denmark helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 38 Denmark helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Denmark helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific helicobacter pylori diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 45 Japan helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 46 Japan helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 China helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 48 China helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 49 China helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 51 India helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 52 India helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Australia helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 54 Australia helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Australia helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Thailand helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 57 Thailand helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Thailand helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 South Korea helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 60 South Korea helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 61 South Korea helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 63 Latin America helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Latin America helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America helicobacter pylori diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 67 Brazil helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Brazil helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Mexico helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 70 Mexico helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Mexico helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa helicobacter pylori diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 South Africa helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 83 South Africa helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 84 South Africa helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Helicobacter pylori diagnostics: Market outlook
  • Fig. 9 Helicobacter pylori diagnostics competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Helicobacter pylori diagnostics market driver impact
  • Fig. 15 Helicobacter pylori diagnostics market restraint impact
  • Fig. 16 Helicobacter pylori diagnostics market strategic initiatives analysis
  • Fig. 17 Helicobacter pylori diagnostics market: Type movement analysis
  • Fig. 18 Helicobacter pylori diagnostics market: Type outlook and key takeaways
  • Fig. 19 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Helicobacter pylori diagnostics market: Technology movement analysis
  • Fig. 23 Helicobacter pylori diagnostics market: Technology outlook and key takeaways
  • Fig. 24 Immunoassays Solid market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 POC market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Helicobacter pylori diagnostics market: End-use movement analysis
  • Fig. 28 Helicobacter pylori diagnostics market: End-use outlook and key takeaways
  • Fig. 29 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Diagnostics laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Global helicobacter pylori diagnostics market: Regional movement analysis
  • Fig. 33 Global helicobacter pylori diagnostics market: Regional outlook and key takeaways
  • Fig. 34 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecasts, ((USD Million) USD Million) 2018 - 2030
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-3-68038-699-8

Helicobacter Pylori Diagnostics Market Growth & Trends:

The global helicobacter pylori diagnostics market size is anticipated to reach USD 757.84 million by 2030, according to a new report by Grand View Research. It is expected to expand at a CAGR of 4.5% over the forecast period. Increasing demand for personalized antibiotic therapy coupled with improved cost-effectiveness Helicobacter pylori (H. pylori) infection diagnosis is projected to drive the growth.

Easy accessibility and affordability of antibiotics along with short treatment durations will boost the adoption of antibiotics as well as the demand for pre and post monitoring tests. Furthermore, factors such as rising incidence of H. pylori infections, need for early diagnosis, and rapid technological advancements in diagnostic techniques will propel the market growth. However, rising pressure of maintaining economic pricing due to the extremely competitive environment may hinder the growth of the Helicobacter pylori diagnostics market.

H. pylori is an aerobic gram-negative bacteria generally found in the stomach. Although advantageous for balancing the stomach ecology, it can cause infection to the inner stomach lining. The bacteria can act as one of the causative agents for stomach cancer, duodenal ulcers, gastritis and gastric ulcers, and infection to the small intestine, among other conditions. This has led to an increase in the demand for Helicobacter pylori diagnostics that enable early detection of H. pylori infection. Patients are subject to an antibiotic therapy for 10 to 14 days, in case of positive diagnosis of ulcers caused by this bacteria. Treatment for H. pylori could include a combination of antibiotics such as metronidazole, amoxicillin, clarithromycin, tetracycline, or with a proton pump inhibitor, ranitidine bismuth citrate, and bismuth subsalicylate.

The immunoassay technology segment held the largest market share in 2018 and is expected to register the fastest CAGR over the forecast period. In terms of end user, the hospital segment held the largest market share in 2018, while diagnostic laboratories is anticipated to expand at the fastest CAGR in the forthcoming years. In terms of region, North America led the global market for Helicobacter pylori diagnostics. Asia Pacific, on the other hand, is expected to witness the fastest CAGR from 2019 to 2026.

Helicobacter Pylori Diagnostics Market Report Highlights:

  • Immunoassays technology held the largest market share in 2022 and is expected to witness the fastest CAGR over the forecast period
  • Among end user, hospital segment held the largest market share in 2022, while the diagnostics laboratories segment is expected to demonstrate the fastest CAGR from 2023 to 2030
  • Latin America is anticipated to grow at the fastest CAGR of 6.4% in the forecast period owing to the rising importance to the healthcare sector, increasing infectious diseases prevalence, and awareness.
  • Key players operating in the Helicobacter pylori diagnostics market include Thermo Fisher Scientific, Biohit, Meridian Bioscience, Bio-Rad Laboratories, F. Hoffmann-La Roche, Alpha Laboratories, Quest Diagnostics, Coris BioConcept, Certest Biotec, and Epitope Diagnostics

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Technology
    • 1.1.3. End-user
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. End-user outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Helicobacter Pylori Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Helicobacter Pylori Diagnostics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Helicobacter Pylori Diagnostics Market: Type Estimates & Trend Analysis

  • 4.1. Helicobacter Pylori Diagnostics Market: Key Takeaways
  • 4.2. Helicobacter Pylori Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Instruments
    • 4.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Reagents
    • 4.4.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Helicobacter Pylori Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Helicobacter Pylori Diagnostics Market: Key Takeaways
  • 5.2. Helicobacter Pylori Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Immunoassays
    • 5.3.1. Immunoassays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. POC
    • 5.4.1. POC market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Molecular Diagnostics
    • 5.5.1. Molecular diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Helicobacter Pylori Diagnostics: End-user Estimates & Trend Analysis

  • 6.1. Helicobacter Pylori Diagnostics Market: Key Takeaways
  • 6.2. Helicobacter Pylori Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Diagnostics Laboratories
    • 6.4.1. Diagnostics laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Clinics
    • 6.5.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Helicobacter Pylori Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Helicobacter Pylori Diagnostics Market by Region: Key Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Thermo Fisher Scientific
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Biohit Oyj
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Quest Diagnostics Incorporated
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Meridian Bioscience
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Bio-Rad Laboratories
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Alpha Laboratories Ltd
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. F. Hoffmann-La Roche Ltd
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Coris BioConcept
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Certest Biotec
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Epitope Diagnostics, Inc.
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives